Home / Aztreonam and Beta-lactamase Inhibitor / Spain
ES ATC J01DF51 · updated 2 Nov 2026
Aztreonam and Beta-lactamase Inhibitor shortage in Spain
Is there an Aztreonam and Beta-lactamase Inhibitor shortage in Spain?
Yes. As of 2 Nov 2026, 1 Aztreonam and Beta-lactamase Inhibitor product is reported short in Spain, the first since 7 Jul 2026. The company estimate for the return is 20 Dec 2026. Main reason: not stated.
Also short in Germany, Italy. All countries.
Affected products in Spain
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| ES | EMBLAVEO 1,5 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 10 viales | Pfizer Europe Ma Eeig | 7 Jul 2026 | 20 Dec 2026 | Not stated |
Source
AEMPS (Spanish Agency of Medicines and Medical Devices), CIMA. Official list. All authorised presentations with a declared supply problem.